DaVita Inc V.DVA

Primary Symbol: DVA

Healthcare

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

NYSE:DVA - Post by User

DaVita Inc > Q&A with Delivra’s Investor Relations Team

<< Previous

Bullboard Posts

Next >>

Comment by mjinvestor88on Dec 14, 2017 2:01pm

58 Views

Post# 27158015

RE:Q&A with Delivra’s Investor Relations Team

These articles are great! I really appreciate all the work you have done in gathering this info. Keep up the good work!

Do you know any more about the deal with Kaly? Is that related to the GVHD formulation? I’ve had no luck trying to contact them either.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario